News Headlines Article

Stanford licenses cancer-fighting drug to S.F. biotech startup
San Francisco Business Times

A San Francisco biotech startup will work with Stanford researchers in their development of a drug that could help stop the spread of cancer throughout a patient’s body.

Ruga Corp. has been granted the license to the Stanford team’s technology, according to a story in the San Francisco Chronicle. The new treatment has only been tested so far on mice, but it appears to disrupt metastasis, the process by which cancer cells break away from original tumor sites and grow elsewhere.